Hemogenyx Pharmaceuticals EBITDA vs. Shares Owned By Insiders
| HEMO Stock | 343.40 20.90 6.48% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -5.7 M | Current Value -5.4 M | Quarterly Volatility 1.9 M |
For Hemogenyx Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hemogenyx Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hemogenyx Pharmaceuticals PLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hemogenyx Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hemogenyx Pharmaceuticals PLC over time as well as its relative position and ranking within its peers.
Hemogenyx |
Hemogenyx Pharmaceuticals Shares Owned By Insiders vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Hemogenyx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Hemogenyx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Hemogenyx Pharmaceuticals PLC is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in shares owned by insiders category among its peers . At this time, Hemogenyx Pharmaceuticals' EBITDA is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hemogenyx Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Hemogenyx Shares Owned By Insiders vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Hemogenyx Pharmaceuticals |
| = | (5.73 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Hemogenyx Pharmaceuticals |
| = | 10.27 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Hemogenyx Shares Owned By Insiders Comparison
Hemogenyx Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.
Hemogenyx Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Hemogenyx Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hemogenyx Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Hemogenyx Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Hemogenyx Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.1 M | 1.1 M | |
| Operating Income | -6.5 M | -6.1 M | |
| Income Before Tax | -6.7 M | -6.4 M | |
| Net Loss | -6.7 M | -6.4 M | |
| Total Other Income Expense Net | -230.6 K | -242.2 K | |
| Income Tax Expense | -5.8 K | -5.5 K | |
| Interest Income | 85.3 K | 89.6 K | |
| Net Loss | -6.7 M | -6.4 M | |
| Net Loss | -4.6 M | -4.4 M | |
| Net Interest Income | -230.6 K | -242.2 K | |
| Change To Netincome | 725.5 K | 845.2 K |
Hemogenyx Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Hemogenyx Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hemogenyx Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hemogenyx Pharmaceuticals' important profitability drivers and their relationship over time.
Use Hemogenyx Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hemogenyx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemogenyx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Hemogenyx Pharmaceuticals Pair Trading
Hemogenyx Pharmaceuticals PLC Pair Trading Analysis
The ability to find closely correlated positions to Hemogenyx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemogenyx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemogenyx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemogenyx Pharmaceuticals PLC to buy it.
The correlation of Hemogenyx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hemogenyx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hemogenyx Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hemogenyx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Hemogenyx Pharmaceuticals position
In addition to having Hemogenyx Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.